147 related articles for article (PubMed ID: 6142150)
1. Reversible azoospermia induced by the anabolic steroid 19-nortestosterone.
Schürmeyer T; Knuth UA; Belkien L; Nieschlag E
Lancet; 1984 Feb; 1(8374):417-20. PubMed ID: 6142150
[TBL] [Abstract][Full Text] [Related]
2. Suppression of spermatogenesis to azoospermia by combined administration of GnRH antagonist and 19-nortestosterone cannot be maintained by this non-aromatizable androgen alone.
Behre HM; Kliesch S; Lemcke B; von Eckardstein S; Nieschlag E
Hum Reprod; 2001 Dec; 16(12):2570-7. PubMed ID: 11726576
[TBL] [Abstract][Full Text] [Related]
3. Depot gonadotropin-releasing hormone agonist blunts the androgen-induced suppression of spermatogenesis in a clinical trial of male contraception.
Behre HM; Nashan D; Hubert W; Nieschlag E
J Clin Endocrinol Metab; 1992 Jan; 74(1):84-90. PubMed ID: 1727833
[TBL] [Abstract][Full Text] [Related]
4. Azoospermia induced by 19-nortestosterone.
Parrott RF
Lancet; 1984 Mar; 1(8379):731. PubMed ID: 6143057
[No Abstract] [Full Text] [Related]
5. Combined administration of a gonadotropin-releasing hormone antagonist and testosterone in men induces reversible azoospermia without loss of libido.
Pavlou SN; Brewer K; Farley MG; Lindner J; Bastias MC; Rogers BJ; Swift LL; Rivier JE; Vale WW; Conn PM
J Clin Endocrinol Metab; 1991 Dec; 73(6):1360-9. PubMed ID: 1955518
[TBL] [Abstract][Full Text] [Related]
6. Induction of azoospermia in normal men with combined Nal-Glu gonadotropin-releasing hormone antagonist and testosterone enanthate.
Tom L; Bhasin S; Salameh W; Steiner B; Peterson M; Sokol RZ; Rivier J; Vale W; Swerdloff RS
J Clin Endocrinol Metab; 1992 Aug; 75(2):476-83. PubMed ID: 1639948
[TBL] [Abstract][Full Text] [Related]
7. Clinical trial of 19-nortestosterone-hexoxyphenylpropionate (Anadur) for male fertility regulation.
Knuth UA; Behre H; Belkien L; Bents H; Nieschlag E
Fertil Steril; 1985 Dec; 44(6):814-21. PubMed ID: 3935486
[TBL] [Abstract][Full Text] [Related]
8. Comparison between testosterone enanthate-induced azoospermia and oligozoospermia in a male contraceptive study. III. Higher 5 alpha-reductase activity in oligozoospermic men administered supraphysiological doses of testosterone.
Anderson RA; Wallace AM; Wu FC
J Clin Endocrinol Metab; 1996 Mar; 81(3):902-8. PubMed ID: 8772548
[TBL] [Abstract][Full Text] [Related]
9. Effects of STS-557 and 20 Aet-1 on sperm functions and serum level of testosterone in bonnet monkey (Macaca radiata).
Sharma RK; Das RP
Contraception; 1992 May; 45(5):483-91. PubMed ID: 1623719
[TBL] [Abstract][Full Text] [Related]
10. Effect of anabolic steroids on reproductive function of young stallions.
Squires EL; Todter GE; Berndtson WE; Pickett BW
J Anim Sci; 1982 Mar; 54(3):576-82. PubMed ID: 7085517
[TBL] [Abstract][Full Text] [Related]
11. Reversible hypogonadism and azoospermia as a result of anabolic-androgenic steroid use in a bodybuilder with personality disorder. A case report.
Boyadjiev NP; Georgieva KN; Massaldjieva RI; Gueorguiev SI
J Sports Med Phys Fitness; 2000 Sep; 40(3):271-4. PubMed ID: 11125771
[TBL] [Abstract][Full Text] [Related]
12. Effects of STS 557 on semen and sperm functions in bonnet monkey (Macaca radiata)--a preliminary report.
Majumdar SS; Sharma RK; Das RP
Contraception; 1988 Jun; 37(6):631-41. PubMed ID: 3396360
[TBL] [Abstract][Full Text] [Related]
13. Prostate-sparing effects in primates of the potent androgen 7alpha-methyl-19-nortestosterone: a potential alternative to testosterone for androgen replacement and male contraception.
Cummings DE; Kumar N; Bardin CW; Sundaram K; Bremner WJ
J Clin Endocrinol Metab; 1998 Dec; 83(12):4212-9. PubMed ID: 9851754
[TBL] [Abstract][Full Text] [Related]
14. Potential of testosterone buciclate for male contraception: endocrine differences between responders and nonresponders.
Behre HM; Baus S; Kliesch S; Keck C; Simoni M; Nieschlag E
J Clin Endocrinol Metab; 1995 Aug; 80(8):2394-403. PubMed ID: 7543113
[TBL] [Abstract][Full Text] [Related]
15. Effect of 19-norandrostenololylaurate on semen characteristics of colts.
Koskinen E; Marttila P; Katila T
Acta Vet Scand; 1997; 38(1):41-50. PubMed ID: 9129345
[TBL] [Abstract][Full Text] [Related]
16. Combined administration of levonorgestrel and testosterone induces more rapid and effective suppression of spermatogenesis than testosterone alone: a promising male contraceptive approach.
Bebb RA; Anawalt BD; Christensen RB; Paulsen CA; Bremner WJ; Matsumoto AM
J Clin Endocrinol Metab; 1996 Feb; 81(2):757-62. PubMed ID: 8636300
[TBL] [Abstract][Full Text] [Related]
17. Chronic administration of nandrolone decanoate does not increase the plasma homocysteine level of male rats.
Mirkhani H; Golbahar J; Shokri S
Basic Clin Pharmacol Toxicol; 2005 Oct; 97(4):214-7. PubMed ID: 16176555
[TBL] [Abstract][Full Text] [Related]
18. Low dose of cyproterone acetate and testosterone enanthate for contraception in men.
Meriggiola MC; Bremner WJ; Costantino A; Di Cintio G; Flamigni C
Hum Reprod; 1998 May; 13(5):1225-9. PubMed ID: 9647551
[TBL] [Abstract][Full Text] [Related]
19. Establishing the minimum effective dose and additive effects of depot progestin in suppression of human spermatogenesis by a testosterone depot.
Handelsman DJ; Conway AJ; Howe CJ; Turner L; Mackey MA
J Clin Endocrinol Metab; 1996 Nov; 81(11):4113-21. PubMed ID: 8923869
[TBL] [Abstract][Full Text] [Related]
20. Steroidal contraception for men.
Sarkar NN
Int J Clin Pract; 2000 Nov; 54(9):594-603. PubMed ID: 11220988
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
